跳至主要内容
临床试验/NCT02350335
NCT02350335已完成不适用

Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Cerebral vasospasm

研究概览

简要总结

All patients with acute aneurysmal hemorrhage are treated in accordance with our institutional protocol. After securing of the aneurysm, some smokers with acute aneurysmal hemorrhage are randomly assigned to transdermal nicotine replacement (NRT). The short- and long-term effect of NRT will be studied comparing non-smokers, smokers without NRT and smokers with NRT.

详细描述

Various aspects of the study:

  • Study cerebral circulation with transcranial Doppler ultrasonography (TCD) prior to and after NRT.
  • Study cardiac output and peripheral vessel resistance minimally invasive (LiDCO) prior to and after NRT in patients that already have established LiDCO.
  • Monitor intracranial pressure prior to and after NRT in patients that have established an intracranial pressure sensor.
  • Register the frequency of cerebral vasospasm and complications in non-smokers, smokers without NRT, and smokers with NRT.
  • Register the use of opioids, opioidanesthetics, propofol og psycholeptics in non-smokers, smokers without NRT, and smokers with NRT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aneurysmal subarachnoid hemorrhage after securing of the aneurysm and surviving the first 2 weeks.

排除标准

  • manifest cerebral vasospasm at arrival at our department (i.e. before securing of the aneurysm)

研究组 & 干预措施

NRT

Active Comparator

Active smokers with acute aneurysmal hemorrhage randomly assigned to transdermal nicotine replacement after securing of the aneurysm.

Patient management for all patients is according to the institutional treatment guidelines and independent of group assignment.

The dose is dependent on smoke consumption prior to the ictus. Nicorette 7 mg/day for smokers smoking 1-10 cigarettes /day Nicorette 14mg/day for smokers smoking 11-19 cigarettes/day Nicorette 21 mg/day for smokers smoking 20 or more cigarettes daily

干预措施: Nicotine (transdermal) (Drug)

结局指标

主要结局

Cerebral vasospasm

时间窗: 21 days

Frequency of cerebral vasospasm within 21 days after the ictus. The institutional protocol for management of aneurysmal hemorrhage is followed in diagnosing cerebral vasospasm. This includes monitoring for cerebral vasospasm with transcranial Doppler ultrasonography and a cerebral computed tomography angiogram on day 7 after the ictus. Digital subtraction angiography is performed when necessary. All patients are monitored in the intensive care or intermediate care unit for clinical signs of cerebral vasospasm.

次要结局

  • Drug consumption(as long as the patient is in the intensive care unit)
  • Cerebral infarction(3-6 months)
  • Complications(3-6 months)
  • Functional outcome(3 and 12 months)
  • Smoking status(1 year)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Angelika Sorteberg

Md, PhD

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验